Rainbow Childrens Medicare · NSE: RAINBOW · BSE: 543524

Q4 FY25 results · Jan–Mar 2025

Rainbow Childrens Medicare reported revenue from operations of ₹370.11 crore (up 8.5% from Q4 FY24) and net profit of ₹56.55 crore (up 10.7% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue from operations370.11341.10+8.5%398.08−7.0%
Other income14.5312.78+13.7%13.27+9.4%
Total income384.63353.88+8.7%411.36−6.5%
Profit before tax76.9769.17+11.3%94.33−18.4%
Net profit for the period56.5551.06+10.7%68.94−18.0%
Attributable to shareholders of the company56.3450.97+10.5%68.69−18.0%
EPS, basic (₹)5.555.02+10.6%6.76−17.9%
Net margin (%)15.315.017.3
Standalone · ₹ crore
ItemQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue from operations354.00325.76+8.7%381.56−7.2%
Other income13.8912.23+13.6%12.85+8.1%
Total income367.89337.99+8.8%394.41−6.7%
Profit before tax74.7568.42+9.2%92.11−18.9%
Net profit for the period54.5450.44+8.1%66.97−18.6%
EPS, basic (₹)5.374.97+8.0%6.60−18.6%
Net margin (%)15.415.517.6
Consolidated
Filed with BSE
24 May 2025, 21:12 IST
Board meeting
24 May 2025
Period
01 Jan 2025 to 31 Mar 2025
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
24 May 2025, 21:12 IST
Board meeting
24 May 2025
Period
01 Jan 2025 to 31 Mar 2025
Review status
Audited
Source
XBRL filing on BSE